ArticleFrontiers in oncology2024

An early combination of concurrent chemoradiotherapy with immune checkpoint inhibitors for cervical cancer is superior to a late combination: a propensity-score matching analysis.

Yi-Ming Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.